RxDoctor Payments DataLook up a doctor →

Kashyap Patel, MD

Clinical Neurophysiology · Statesboro, GANPI 1700947231

Payments from drug & device makers

$199,387in general payments, 2019–2025

Across 1,202 payments — averaging $165.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$113K
  • Biohaven Pharmaceutical Holding Company Ltd.$24K
  • Biohaven Pharmaceuticals, Inc.$23K
  • Impel Pharmaceuticals Inc.$14K
  • Teva Pharmaceuticals USA, Inc.$8K
  • Livanova USA, Inc.$2K
  • plus $15K from 51 others
$584in research payments, 2019–2025

Across 1 payment — averaging $584.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$584

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)277$113,075
Biohaven Pharmaceutical Holding Company Ltd.33$23,586
Biohaven Pharmaceuticals, Inc.51$22,762
Impel Pharmaceuticals Inc.32$14,168
Teva Pharmaceuticals USA, Inc.82$8,435
Livanova USA, Inc.17$2,213
Novartis82$1,622
Amgen55$1,000
UCB, Inc.45$942
Eisai Inc.43$933
Neurelis, Inc.37$750
EMD Serono, Inc.25$722
Scilex Pharmaceuticals Inc.33$677
SK Life Science, Inc.33$670
Genentech USA, Inc.31$656
Pfizer31$634
Lilly USA, LLC37$600
Catalyst Pharmaceuticals, Inc.25$585
Kyowa Kirin, Inc.23$410
Sanofi7$363
Adamas Pharmaceuticals, Inc.19$354
Johnson & Johnson(2 entities)10$334
Argenx US, Inc.15$303
Jazz Pharmaceuticals Inc.11$289
AstraZeneca13$275
Lundbeck LLC13$267
Sunovion Pharmaceuticals Inc.12$252
Biogen14$249
Tanabe Pharma America, Inc.14$246
Neurocrine Biosciences, Inc.10$218
TG Therapeutics, Inc.5$193
Sumitomo Pharma America, Inc.9$179
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)3$165
E.r. Squibb & Sons, L.L.C.3$156
Avanir Pharmaceuticals, Inc.6$108
Banner Life Sciences, LLC6$104
Upsher-smith Laboratories LLC4$85
CSL Behring3$82
Otsuka America Pharmaceutical, Inc.4$82
Sobi, Inc1$70
Bristol Myers Squibb4$68
Acadia Pharmaceuticals Inc4$67
Boston Scientific3$63
Averitas Pharma Inc.2$54
Regeneron Healthcare Solutions, Inc.1$48
Bausch Health US, LLC2$46
Supernus Pharmaceuticals, Inc.2$33
Impel Pharmaceuticals LLC1$25
Azurity Pharmaceuticals, Inc.1$24
Amarin Pharma, Inc.1$23
Vivus LLC1$22
Aprecia Pharmaceuticals, LLC1$21
Saol Therapeutics Inc.1$18
MDD US Operations, LLC1$17
Grifols USA, LLC1$16
GSK1$15
GE HealthCare1$15

How this compares

Too few clinical neurophysiology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$166,701
Medicare patients
349
Services billed
1,496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical neurophysiology in Statesboro

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →